Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...
abc13

CA calls for pausing distribution on one lot of Moderna vaccine after allergic reactions reported

CALIFORNIA -- California health officials are recommending a temporary halt to distribution of a particular lot of Moderna's COVID-19 vaccine out of concern over allergic reactions. More than 330,000 ...

Moderna Flu And RSV Data Highlight Push Beyond COVID And Valuation Tension

Moderna (NasdaqGS:MRNA) reported positive Phase 3 clinical data for its investigational influenza vaccine mRNA-1010 and RSV ...

Japan poised to advise that males 10-29 get Pfizer over Moderna

The health ministry is preparing to recommend males in their teens and 20s get the Pfizer COVID-19 vaccine instead of Moderna ...
FOX 5 Atlanta

Study shows Moderna’s COVID-19 vaccine could lead to more side effects than Pfizer/BioNTech’s

New research from the U.S. Centers for Disease Control and Prevention suggests that people who receive Moderna’s COVID-19 vaccine might experience more side effects than those who get ...